Cargando…

Prominent epigenetic and transcriptomic changes in CD4(+) and CD8(+) T cells during and after pregnancy in women with multiple sclerosis and controls

BACKGROUND: Multiple sclerosis (MS) is a neuroinflammatory disease in which pregnancy leads to a temporary amelioration in disease activity as indicated by the profound decrease in relapses rate during the 3rd trimester of pregnancy. CD4(+) and CD8(+) T cells are implicated in MS pathogenesis as bei...

Descripción completa

Detalles Bibliográficos
Autores principales: Zenere, Alberto, Hellberg, Sandra, Papapavlou Lingehed, Georgia, Svenvik, Maria, Mellergård, Johan, Dahle, Charlotte, Vrethem, Magnus, Raffetseder, Johanna, Khademi, Mohsen, Olsson, Tomas, Blomberg, Marie, Jenmalm, Maria C., Altafini, Claudio, Gustafsson, Mika, Ernerudh, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134602/
https://www.ncbi.nlm.nih.gov/pubmed/37106402
http://dx.doi.org/10.1186/s12974-023-02781-2
_version_ 1785031796614758400
author Zenere, Alberto
Hellberg, Sandra
Papapavlou Lingehed, Georgia
Svenvik, Maria
Mellergård, Johan
Dahle, Charlotte
Vrethem, Magnus
Raffetseder, Johanna
Khademi, Mohsen
Olsson, Tomas
Blomberg, Marie
Jenmalm, Maria C.
Altafini, Claudio
Gustafsson, Mika
Ernerudh, Jan
author_facet Zenere, Alberto
Hellberg, Sandra
Papapavlou Lingehed, Georgia
Svenvik, Maria
Mellergård, Johan
Dahle, Charlotte
Vrethem, Magnus
Raffetseder, Johanna
Khademi, Mohsen
Olsson, Tomas
Blomberg, Marie
Jenmalm, Maria C.
Altafini, Claudio
Gustafsson, Mika
Ernerudh, Jan
author_sort Zenere, Alberto
collection PubMed
description BACKGROUND: Multiple sclerosis (MS) is a neuroinflammatory disease in which pregnancy leads to a temporary amelioration in disease activity as indicated by the profound decrease in relapses rate during the 3rd trimester of pregnancy. CD4(+) and CD8(+) T cells are implicated in MS pathogenesis as being key regulators of inflammation and brain lesion formation. Although Tcells are prime candidates for the pregnancy-associated improvement of MS, the precise mechanisms are yet unclear, and in particular, a deep characterization of the epigenetic and transcriptomic events that occur in peripheral T cells during pregnancy in MS is lacking. METHODS: Women with MS and healthy controls were longitudinally sampled before, during (1st, 2nd and 3rd trimesters) and after pregnancy. DNA methylation array and RNA sequencing were performed on paired CD4(+) and CD8(+) T cells samples. Differential analysis and network-based approaches were used to analyze the global dynamics of epigenetic and transcriptomic changes. RESULTS: Both DNA methylation and RNA sequencing revealed a prominent regulation, mostly peaking in the 3rd trimester and reversing post-partum, thus mirroring the clinical course with improvement followed by a worsening in disease activity. This rebound pattern was found to represent a general adaptation of the maternal immune system, with only minor differences between MS and controls. By using a network-based approach, we highlighted several genes at the core of this pregnancy-induced regulation, which were found to be enriched for genes and pathways previously reported to be involved in MS. Moreover, these pathways were enriched for in vitro stimulated genes and pregnancy hormones targets. CONCLUSION: This study represents, to our knowledge, the first in-depth investigation of the methylation and expression changes in peripheral CD4(+) and CD8(+) T cells during pregnancy in MS. Our findings indicate that pregnancy induces profound changes in peripheral T cells, in both MS and healthy controls, which are associated with the modulation of inflammation and MS activity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-023-02781-2.
format Online
Article
Text
id pubmed-10134602
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101346022023-04-28 Prominent epigenetic and transcriptomic changes in CD4(+) and CD8(+) T cells during and after pregnancy in women with multiple sclerosis and controls Zenere, Alberto Hellberg, Sandra Papapavlou Lingehed, Georgia Svenvik, Maria Mellergård, Johan Dahle, Charlotte Vrethem, Magnus Raffetseder, Johanna Khademi, Mohsen Olsson, Tomas Blomberg, Marie Jenmalm, Maria C. Altafini, Claudio Gustafsson, Mika Ernerudh, Jan J Neuroinflammation Research BACKGROUND: Multiple sclerosis (MS) is a neuroinflammatory disease in which pregnancy leads to a temporary amelioration in disease activity as indicated by the profound decrease in relapses rate during the 3rd trimester of pregnancy. CD4(+) and CD8(+) T cells are implicated in MS pathogenesis as being key regulators of inflammation and brain lesion formation. Although Tcells are prime candidates for the pregnancy-associated improvement of MS, the precise mechanisms are yet unclear, and in particular, a deep characterization of the epigenetic and transcriptomic events that occur in peripheral T cells during pregnancy in MS is lacking. METHODS: Women with MS and healthy controls were longitudinally sampled before, during (1st, 2nd and 3rd trimesters) and after pregnancy. DNA methylation array and RNA sequencing were performed on paired CD4(+) and CD8(+) T cells samples. Differential analysis and network-based approaches were used to analyze the global dynamics of epigenetic and transcriptomic changes. RESULTS: Both DNA methylation and RNA sequencing revealed a prominent regulation, mostly peaking in the 3rd trimester and reversing post-partum, thus mirroring the clinical course with improvement followed by a worsening in disease activity. This rebound pattern was found to represent a general adaptation of the maternal immune system, with only minor differences between MS and controls. By using a network-based approach, we highlighted several genes at the core of this pregnancy-induced regulation, which were found to be enriched for genes and pathways previously reported to be involved in MS. Moreover, these pathways were enriched for in vitro stimulated genes and pregnancy hormones targets. CONCLUSION: This study represents, to our knowledge, the first in-depth investigation of the methylation and expression changes in peripheral CD4(+) and CD8(+) T cells during pregnancy in MS. Our findings indicate that pregnancy induces profound changes in peripheral T cells, in both MS and healthy controls, which are associated with the modulation of inflammation and MS activity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-023-02781-2. BioMed Central 2023-04-27 /pmc/articles/PMC10134602/ /pubmed/37106402 http://dx.doi.org/10.1186/s12974-023-02781-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zenere, Alberto
Hellberg, Sandra
Papapavlou Lingehed, Georgia
Svenvik, Maria
Mellergård, Johan
Dahle, Charlotte
Vrethem, Magnus
Raffetseder, Johanna
Khademi, Mohsen
Olsson, Tomas
Blomberg, Marie
Jenmalm, Maria C.
Altafini, Claudio
Gustafsson, Mika
Ernerudh, Jan
Prominent epigenetic and transcriptomic changes in CD4(+) and CD8(+) T cells during and after pregnancy in women with multiple sclerosis and controls
title Prominent epigenetic and transcriptomic changes in CD4(+) and CD8(+) T cells during and after pregnancy in women with multiple sclerosis and controls
title_full Prominent epigenetic and transcriptomic changes in CD4(+) and CD8(+) T cells during and after pregnancy in women with multiple sclerosis and controls
title_fullStr Prominent epigenetic and transcriptomic changes in CD4(+) and CD8(+) T cells during and after pregnancy in women with multiple sclerosis and controls
title_full_unstemmed Prominent epigenetic and transcriptomic changes in CD4(+) and CD8(+) T cells during and after pregnancy in women with multiple sclerosis and controls
title_short Prominent epigenetic and transcriptomic changes in CD4(+) and CD8(+) T cells during and after pregnancy in women with multiple sclerosis and controls
title_sort prominent epigenetic and transcriptomic changes in cd4(+) and cd8(+) t cells during and after pregnancy in women with multiple sclerosis and controls
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134602/
https://www.ncbi.nlm.nih.gov/pubmed/37106402
http://dx.doi.org/10.1186/s12974-023-02781-2
work_keys_str_mv AT zenerealberto prominentepigeneticandtranscriptomicchangesincd4andcd8tcellsduringandafterpregnancyinwomenwithmultiplesclerosisandcontrols
AT hellbergsandra prominentepigeneticandtranscriptomicchangesincd4andcd8tcellsduringandafterpregnancyinwomenwithmultiplesclerosisandcontrols
AT papapavloulingehedgeorgia prominentepigeneticandtranscriptomicchangesincd4andcd8tcellsduringandafterpregnancyinwomenwithmultiplesclerosisandcontrols
AT svenvikmaria prominentepigeneticandtranscriptomicchangesincd4andcd8tcellsduringandafterpregnancyinwomenwithmultiplesclerosisandcontrols
AT mellergardjohan prominentepigeneticandtranscriptomicchangesincd4andcd8tcellsduringandafterpregnancyinwomenwithmultiplesclerosisandcontrols
AT dahlecharlotte prominentepigeneticandtranscriptomicchangesincd4andcd8tcellsduringandafterpregnancyinwomenwithmultiplesclerosisandcontrols
AT vrethemmagnus prominentepigeneticandtranscriptomicchangesincd4andcd8tcellsduringandafterpregnancyinwomenwithmultiplesclerosisandcontrols
AT raffetsederjohanna prominentepigeneticandtranscriptomicchangesincd4andcd8tcellsduringandafterpregnancyinwomenwithmultiplesclerosisandcontrols
AT khademimohsen prominentepigeneticandtranscriptomicchangesincd4andcd8tcellsduringandafterpregnancyinwomenwithmultiplesclerosisandcontrols
AT olssontomas prominentepigeneticandtranscriptomicchangesincd4andcd8tcellsduringandafterpregnancyinwomenwithmultiplesclerosisandcontrols
AT blombergmarie prominentepigeneticandtranscriptomicchangesincd4andcd8tcellsduringandafterpregnancyinwomenwithmultiplesclerosisandcontrols
AT jenmalmmariac prominentepigeneticandtranscriptomicchangesincd4andcd8tcellsduringandafterpregnancyinwomenwithmultiplesclerosisandcontrols
AT altafiniclaudio prominentepigeneticandtranscriptomicchangesincd4andcd8tcellsduringandafterpregnancyinwomenwithmultiplesclerosisandcontrols
AT gustafssonmika prominentepigeneticandtranscriptomicchangesincd4andcd8tcellsduringandafterpregnancyinwomenwithmultiplesclerosisandcontrols
AT ernerudhjan prominentepigeneticandtranscriptomicchangesincd4andcd8tcellsduringandafterpregnancyinwomenwithmultiplesclerosisandcontrols